Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month Study
Determination of the Antiplaque/Antigingivitis Efficacy of Essential Oil Containing Mouthrinses In a Six-Month Study
1 other identifier
interventional
370
1 country
1
Brief Summary
The objective of this randomized, single-center, examiner-blind, controlled, parallel group, six-month clinical study is to compare the antiplaque/antigingivitis potential of a no-alcohol essential oil containing mouthrinse and an alcohol essential oil containing mouthrinse. A negative control group using only an ADA Accepted anticavity toothpaste will be included.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 30, 2016
CompletedFirst Posted
Study publicly available on registry
December 2, 2016
CompletedDecember 2, 2016
November 1, 2016
6 months
November 30, 2016
November 30, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean Modified Gingival Index (MGI) at 6 Months
Gingivitis was assessed on the buccal and lingual marginal gingivae and interdental papillae on all scoreable teeth on a 5-grade categorical scale of 0=normal to 4=severe inflammation.
6 Months
Secondary Outcomes (8)
Mean Modified Gingival Index (MGI) at 1 Month
1 Month
Mean Modified Gingival Index (MGI) at 3 Months
3 Months
Mean Gingival Bleeding Index (BI) at 1 Month
1 Month
Mean Gingival Bleeding Index (BI) at 3 Months
3 Months
Mean Gingival Bleeding Index (BI) at 6 Months
6 Months
- +3 more secondary outcomes
Study Arms (3)
Listerine Zero Mouthwash (without alcohol)
ACTIVE COMPARATORBrushing twice daily in the usual manner with an ADA-Accepted Fluoride Toothpaste (Colgate Cavity Protection) using a soft-bristled toothbrush and rinsing with 20 ml of Listerine Zero Mouthwash (without alcohol) for 30 seconds.
Listerine Antiseptic Mouthwash (with alcohol)
ACTIVE COMPARATORBrushing twice daily in the usual manner with an ADA-Accepted Fluoride Toothpaste (Colgate Cavity Protection) using a soft-bristled toothbrush and rinsing with 20 ml of Listerine Antiseptic Mouthwash (with alcohol) for 30 seconds.
Brush only
NO INTERVENTIONBrush only twice daily in the usual manner with an ADA-Accepted Fluoride Toothpaste (Colgate Cavity Protection) using a soft-bristled toothbrush.
Interventions
20 ml of rinse for 30 seconds, twice a day
20 ml of rinse for 30 seconds, twice a day
Eligibility Criteria
You may qualify if:
- Males and females 18 years of age or older, in good general and oral health, except gingivitis.
- Able to comprehend and follow the requirements of the study (including availability on scheduled visit dates) based upon research site personnel's assessment;
- Evidence of a personally signed and dated informed consent document indicating the subject (or legally acceptable representative) has been informed of all pertinent aspects of the trial.
- A minimum of 20 natural teeth with scorable facial and lingual surfaces. Teeth that are grossly carious, extensively restored, orthodontically banded, abutments, exhibiting severe generalized cervical and/or enamel abrasion, or third molars will not be included in the tooth count.
- A mean gingival index ≥ 1.75 according to the Modified Gingival Index.
- A mean plaque index ≥ 1.95 according to the Turesky modification of the Quigley-Hein Plaque Index scored on six surfaces per tooth.
- Absence of significant oral soft tissue pathology, excluding plaque-induced gingivitis, based on a visual examination and at the discretion of the Investigator.
- Absence of moderate/advanced periodontitis based on a clinical examination (ADA Type III, IV).
- Absence of fixed or removable orthodontic appliance or removable partial dentures.
You may not qualify if:
- History of significant adverse effects, including sensitivities or suspected allergies, following use of oral hygiene products such as toothpastes and mouthrinses and red food dye.
- History of serious medical conditions that, at the discretion of the Investigator, will disqualify the subject.
- History of rheumatic fever, heart murmur, mitral valve prolapse or other conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures.
- Antibiotic, anti-inflammatory or anticoagulant therapy during the study or within the 2 weeks prior to the baseline exam.
- Regular use of chemotherapeutic antiplaque/antigingivitis products such as triclosan, essential oil, cetylpyridinium chloride, or chlorhexidine containing mouthrinses within the 2 weeks prior to baseline.
- Current or history of alcohol or drug abuse.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Taubate
Taubaté, São Paulo, 12020-270, Brazil
Related Publications (1)
Lynch MC, Cortelli SC, McGuire JA, Zhang J, Ricci-Nittel D, Mordas CJ, Aquino DR, Cortelli JR. The effects of essential oil mouthrinses with or without alcohol on plaque and gingivitis: a randomized controlled clinical study. BMC Oral Health. 2018 Jan 10;18(1):6. doi: 10.1186/s12903-017-0454-6.
PMID: 29321067DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jose Cortelli, Ph. D
Universidade de Taubate
- STUDY CHAIR
Sheila Cortelli, Ph.D
Universidade de Taubate
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 30, 2016
First Posted
December 2, 2016
Study Start
September 1, 2013
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
December 2, 2016
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will not share